Queen’s Park Equity (QPE) has announced its support for the management buyout (MBO) of MediMatch, a rapidly growing digital dental laboratory in the UK. MediMatch serves over 2,000 dentists across the UK and has expanded its operations to Europe, with labs in Dublin, Milan, and Paris.

The company has experienced approximately 20% annual growth over the past three years, driven by its digital-first strategy in a fragmented market. QPE sees significant potential for further consolidation in the UK and EU dental laboratory sector, particularly as the market benefits from an increase in privately funded dental treatments and the rising use of intra-oral scanners by dentists worldwide.

Hugo Van Loenen, founder and CEO of MediMatch, expressed enthusiasm about partnering with QPE, highlighting the value of their sector expertise and buy-and-build capabilities in executing an accelerated growth plan. Sami Igout from QPE echoed this sentiment, emphasizing their excitement to support MediMatch in building on its impressive organic growth, which is attributed to its efficient, digital-led service model.

Jonny Kay, Managing Partner at QPE, noted that this investment underscores the strength of their thematic-led research and sourcing capabilities. MediMatch marks the eleventh partnership investment from QPE Fund I, which closed at its hard cap of £202 million in December 2020. The fund recently achieved its first exit at a 7.6x multiple through the sale of Encore.

QPE is dedicated to providing capital and expertise to high-quality, entrepreneur-led businesses in sectors such as Healthcare & Pharma, Education, and Tech-Enabled Business Services, with a strong focus on accelerating growth.